We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Urinary Antigen Test Kit Evaluated for Diagnosing Legionella Pneumonia

By LabMedica International staff writers
Posted on 24 Feb 2021
Print article
Image: The BinaxNOW Legionella Urinary Antigen Card. Accurate. Rapid identification of Legionnaires` disease caused by Legionella pneumophila serogroup 1 with an easy-to-use technology (Photo courtesy of Abbott).
Image: The BinaxNOW Legionella Urinary Antigen Card. Accurate. Rapid identification of Legionnaires` disease caused by Legionella pneumophila serogroup 1 with an easy-to-use technology (Photo courtesy of Abbott).
Legionellosis is caused by bacteria called Legionella. The disease has two different forms. Legionnaires’ disease is the more severe form of infection that causes pneumonia. Pontiac fever is caused by the same bacteria, but is a milder illness without pneumonia.

Various examinations are performed for the diagnosis of Legionella pneumonia, including urinary antigen tests, respiratory specimen cultures, nucleic acid detection tests, and serum antibody tests. Although culture of Legionella species from a respiratory specimen is the diagnostic gold standard, it is time consuming. L. pneumophila is divided into 15 serogroups (SG).

A large team of medical microbiologists and their colleagues at Kurashiki Central Hospital (Kurashiki, Japan) enrolled prospectively pneumonia patients suspected by attending physicians to have disease caused by Legionella species based on symptoms, laboratory examinations, and radiological findings, and whose urine samples could be collected, from 16 hospitals in Japan from April 2016 to December 2018.

Three urinary antigen test kits were used: the novel kit (LAC-116 Asahi Kasei Pharma Corporation, Tokyo, Japan), BinaxNOW Legionella (Binax, Abbott Park, IL, USA), and Q-line Kyokutou Legionella (Q-line, Kyokutou Corporation, Tokyo, Japan). In addition, sputum culture and nucleic acid detection tests and serum antibody tests were performed where possible. The diagnostic accuracy and correlations of the novel kit with the two existing kits were analyzed.

The scientists reported that in total, 56 patients were diagnosed with Legionella pneumonia. The sensitivities of LAC-116, Binax, and Q-line were 79%, 84%, and 71%, respectively. The overall match rate between LAC-116 and Binax was 96.8% and between LAC-116 and Q-line was 96.4%. One patient had L. pneumophila serogroup 2, and only LAC-116 showed a positive result, whereas Binax and Q-line did not.

The authors concluded that the novel kit can theoretically diagnose Legionella pneumonia due to both L. pneumophila SG1 and non-SG1, and it is therefore useful for diagnosing Legionella pneumonia. In the future, early and appropriate diagnosis of Legionella pneumonia due to non-L. pneumophila SG1 can be expected with this novel kit. The team believes that the use of this kit may improve the prognosis of Legionella pneumonia patients. The study was published on February 1, 2021 in the International Journal of Infectious Diseases.

Related Links:
Kurashiki Central Hospital
Asahi Kasei Pharma Corporation
Binax
Kyokutou Corporation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.